Vistin Pharma ASA (OSL:VISTN)
Norway flag Norway · Delayed Price · Currency is NOK
20.30
-0.30 (-1.46%)
At close: Jul 15, 2026

Vistin Pharma ASA Balance Sheet

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Short-Term Investments
6.3316.4212.826.21.4435.75
Cash Growth
-50.04%28.31%-51.17%1726.06%-95.99%-53.60%
Accounts Receivable
100.1689.7144.2847.0266.1640.25
Other Receivables
28.1215.269.4515.388.1518.93
Total Trade Receivables
128.28104.9753.7362.474.359.18
Inventory
82.9382.1376.6780.1783.4542.91
Total Current Assets
217.54203.52143.19168.77159.18137.83
Net Property, Plant & Equipment
223.87223.75229.6219.98219.43167.46
Long-Term Investments
12.1512.1512.15---
Other Long-Term Assets
---14.6428.627.86
Total Assets
453.56439.43384.95403.4407.21333.15
Accounts Payable
25.4130.2413.0518.9225.9120.81
Accrued Expenses
-7.73----
Short-Term Debt
----45.14-
Other Current Liabilities
48.1148.7550.9150.5646.5320.23
Total Current Liabilities
73.5286.7263.9769.47117.5741.04
Other Long-Term Liabilities
29.7423.911.4511.1516.1616.34
Total Long-Term Liabilities
29.7423.911.4511.1516.1616.34
Total Liabilities
103.25110.6275.4180.62133.7357.38
Common Stock
44.3544.3544.3544.3544.3544.35
Additional Paid-in Capital
73.8773.87129.3206.89206.89206.89
Retained Earnings
232.09210.6135.8971.5422.2624.54
Shareholders' Equity
350.31328.81309.53322.77273.49275.77
Total Liabilities & Equity
453.56439.43384.95403.4407.21333.15
Total Debt
-00045.140
Net Cash (Debt)
6.3316.4212.826.2-43.7135.75
Net Cash Growth
-61.45%28.31%-51.17%---53.60%
Net Cash Per Share
0.140.370.290.59-0.990.81
Book Value
350.31328.81309.53322.77273.49275.77
Book Value Per Share
7.907.416.987.286.176.22
Tangible Book Value
350.31328.81309.53322.77273.49275.77
Tangible Book Value Per Share
7.907.416.987.286.176.22